Last $25.81 USD
Change Today -0.079 / -0.31%
Volume 8.3K
As of 9:46 AM 05/20/13 All times are local (Market data is delayed by at least 15 minutes).

on assignment inc (ASGN) Snapshot

Open
$25.75
Previous Close
$25.72
Day High
$25.88
Day Low
$25.75
52 Week High
05/14/13 - $26.91
52 Week Low
06/28/12 - $14.48
Market Cap
1.4B
Average Volume 10 Days
299.0K
EPS TTM
$1.03
Shares Outstanding
53.3M
EX-Date
--
P/E TM
25.1x
Dividend
--
Dividend Yield
--
Current Stock Chart for ON ASSIGNMENT INC (ASGN)

Related News

No related news articles were found.

on assignment inc (ASGN) Related Businessweek News

View More BusinessWeek News

on assignment inc (ASGN) Details

On Assignment, Inc., a diversified professional staffing firm, provides short- and long-term placement of contract, contract-to-hire, and direct hire professionals in the United States, Europe, Canada, China, Australia, and New Zealand. The company operates in five segments: Apex, Oxford, Life Sciences, Healthcare, and Physician. The Apex segment provides mission-critical information technology (IT) operations professionals for contract, contract-to-hire, and permanent placement positions to Fortune 1000 and mid-market clients. It serves companies from industries, including financial services, business services, consumer and industrials, technology, healthcare, government services, and communications. The Oxford segment provides high-end contract and direct placement services of IT and engineering professionals in the specialized IT; software and hardware engineering; and mechanical, electrical, validation, and telecommunications engineering fields. The Life Sciences segment offers contract, contract-to-permanent, and direct placement services of laboratory and scientific professionals to the biotechnology, pharmaceutical, food and beverage, medical device, personal care, chemical, and environmental industries. Its contract staffing specialties include chemists, clinical research associates, clinical lab assistants, engineers, biologists, biochemists, microbiologists, molecular biologists, food scientists, regulatory affairs specialists, lab assistants, and other scientific professionals. The Healthcare segment provides professionals, such as nurses, specialty nurses, respiratory therapists, surgical technicians, imaging and X-ray technicians, medical technologists, phlebotomists, coders, billers, claims processors, and collections staff. The Physician segment offers contract and direct placement physicians in hospitals; community-based practices; and federal, state, and local facilities. The company was founded in 1985 and is headquartered in Calabasas, California.

2,500 Employees
Last Reported Date: 03/18/13
Founded in 1985

on assignment inc (ASGN) Top Compensated Officers

Chief Executive Officer, President, Director ...
Total Annual Compensation: $724.4K
Chief Financial Officer, Principal Accounting...
Total Annual Compensation: $147.1K
Chief Operating Officer and President of Oxfo...
Total Annual Compensation: $479.4K
President of Apex Randolph
Total Annual Compensation: $709.6K
President of Life Sciences and Allied Healthc...
Total Annual Compensation: $347.5K
Compensation as of Fiscal Year 2012.

on assignment inc (ASGN) Key Developments

on Assignment Inc. Enters into an Amended and Restated Credit Agreement with Wells Fargo Bank, National Association

On May 16, 2013, On Assignment Inc. entered into an amended and restated credit agreement with Wells Fargo Bank, National Association, as administrative agent, swing line lender and a letter of credit issuer, and the lenders party thereto. The amended and restated credit agreement consists of: a $100.0 million, five-year term A loan facility; a $275.0 million seven-year term B loan facility; and a $125.0 million, five-year revolving loan facility, including a $10.0 million swing line sub facility and a $10.0 million sub facility for letters of credit. The amended and restated credit agreement also provides the ability to increase the loan facilities for up to the greater of $100.0 million and the amount that is equal to the great amount of additional debt that would not cause the Company to exceed certain specified conditions. Borrowings under the amended and restated credit agreement bear interest through maturity at a variable rate based upon, at the Company's option, either the Eurodollar rate or the base rate, plus in each case, an applicable margin. The applicable margin for Eurodollar rate loans for the revolving loans and the term A loans ranges, based on the applicable leverage ratio, from 1.75% to 2.50% per annum and the applicable margin for base rate loans ranges, based on the applicable leverage ratio, from 0.75% to 1.50% per annum. The applicable margin for Eurodollar rate loans for the term B loans is 2.50% per annum and the applicable margin for base rate loans is 1.50% per annum. The company is required to pay a commitment fee equal to 0.40% per annum on the undrawn portion available under the revolving loan facility if its leverage ratio is greater than or equal to 3.00:1.00, a commitment fee equal to 0.35% per annum if its leverage ratio is less than 3.00:1.00 but greater than or equal to 2.50:1.00, a commitment fee equal to 0.30% per annum if its leverage ratio is less than 2.50:1.00 but greater than or equal to 2.00:1.00, and a commitment fee equal to 0.25% per annum if its leverage ratio is less than 2.00:1.00. Additionally, the company is required to pay variable per annum fees equal to the applicable margin for Eurodollar rate loans in respect of outstanding letters of credit. During the five years after the closing date, the company will be required to make quarterly amortization payments on the term A loan facility in the aggregate annual amount equal to 10% of the original principal amount of the term A Loan facility. During the seven years after the closing date, the company will be required to make quarterly amortization payments on the term B loan facility in the aggregate annual amount equal to 1% of the original principal amount of the term B Loan facility. The Company is also required to make mandatory prepayments of loans under the amended and restated credit agreement, subject to specified exceptions, from excess cash flow and with the proceeds of asset sales, debt issuances and specified other events.

On Assignment Inc. Reports Unaudited Consolidated Earnings Results for the First Quarter Ended March 31, 2013; Provides Earnings Guidance for the Second Quarter of 2013; Revised Earnings Guidance for the Full Year of 2013

On Assignment Inc. reported unaudited consolidated earnings results for the first quarter ended March 31, 2013. For the quarter, revenues were $389,193,000 against $156,760,000 a year ago. Operating income was $23,734,000 against $9,370,000 a year ago. Income before income taxes was $18,403,000 against $8,669,000 a year ago. Income from continuing operations was $10,610,000 or $0.20 per basic and diluted share against $5,047,000 or $0.13 per diluted share a year ago. Net income was $24,613,000 or $0.46 per diluted share against $5,383,000 or $0.14 per diluted share a year ago. Capital expenditures were $2,785,000 against $2,119,000 a year ago. EBITDA was $30,968,000 against $11,414,000 a year ago. Adjusted EBITDA was $34,136,000 against $15,078,000 a year ago. Income from continuing operations - as adjusted was $18,789,000 or $0.35 per diluted share. Cash used in operations was $2,869,000 against cash provided by operations of $6,973,000 a year ago. For the second quarter of 2013, the company estimates revenues of $410 million to $414 million, gross margin of 29.8% to 30.1%, adjusted EBITDA of $41 million to $43 million, effective tax rate of 42.5%, adjusted income from continuing operations of $22.5 million to $23.5 million, adjusted income from continuing operations per diluted share of $0.41 to $0.43, income from continuing operations of $14.5 million to $15.5 million and income from continuing operations per diluted share of $0.27 to $0.29. For the full year of 2013, the company expects to trend toward the high-end of the previously-announced full year 2013 targets.

On Assignment Inc., Q1 2013 Earnings Call, Apr 24, 2013

On Assignment Inc., Q1 2013 Earnings Call, Apr 24, 2013

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ASGN:US $25.81 USD -0.079

ASGN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Brunel International NV €33.99 EUR -0.21
MedAssets Inc $18.55 USD -0.10
Meitec Corp ¥2,460 JPY -59.00
Michael Page International PLC 391.70 GBp -1.40
Temp Holdings Co Ltd ¥2,399 JPY -5.00
View Industry Companies
 

Industry Analysis

ASGN

Industry Average

Valuation ASGN Industry Range
Price/Earnings 27.6x
Price/Sales 0.9x
Price/Book 2.4x
Price/Cash Flow 16.2x
TEV/Sales 0.7x
 | 

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ON ASSIGNMENT INC, please visit www.onassignment.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.